Acepodia Biotech Inc.   Report issue

For profit Phase 1
Founded: San Mateo CA United States (2017)

Organization Overview

First Clinical Trial
2020
NCT04319757
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Acepodia Biotech Inc.